Head CT Decision Aid Ups Parent Knowledge in Child Head Trauma

Share this content:
Head CT Decision Aid Ups Parent Knowledge in Child Head Trauma
Head CT Decision Aid Ups Parent Knowledge in Child Head Trauma

WEDNESDAY, Sept. 26, 2018 (HealthDay News) -- Use of a decision aid can improve parent knowledge for children with minor head injury at intermediate risk of clinically important traumatic brain injury (ciTBI), according to a study published online Sept. 21 in JAMA Network Open.

Erik P. Hess, M.D., from the University of Alabama at Birmingham, and colleagues compared a decision aid with usual care in parents of children at intermediate risk for ciTBI. A total of 172 clinicians caring for 971 children with minor head trauma were randomized to shared decision-making facilitated by the Head CT Choice decision aid or usual care (493 and 478, respectively).

The researchers found that, compared with usual care, parents in the decision aid arm had greater knowledge (mean questions correct, 6.2 versus 5.3), exhibited less decisional conflict (mean decisional conflict score, 14.8 versus 19.2), and were more involved in computed tomography decision-making (observing patient involvement score: mean, 25.0 versus 13.3). There was no significant difference between the emergency department computed tomography rate (decision aid, 22 percent versus usual care, 24 percent); the decision aid arm had a lower mean number of imaging tests at seven days after injury. There were no children with missed ciTBI.

"Use of a decision aid in parents of children at intermediate risk of ciTBI increased parent knowledge, decreased decisional conflict, and increased involvement in decision-making," the authors write.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »